Ras, ROS and proteotoxic stress: a delicate balance
- PMID: 21907917
- PMCID: PMC3179373
- DOI: 10.1016/j.ccr.2011.08.020
Ras, ROS and proteotoxic stress: a delicate balance
Abstract
Ras-deregulated cells require reactive oxygen species for proliferation. They survive the resultant proteotoxic stress by maintaining sufficient levels of reduced glutathione and optimally functioning stress response machinery. In this issue of Cancer Cell, De Raedt et al. identify a novel strategy that utilizes this dependency to cause cell death.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Comment on
-
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors.Cancer Cell. 2011 Sep 13;20(3):400-13. doi: 10.1016/j.ccr.2011.08.014. Cancer Cell. 2011. PMID: 21907929 Free PMC article.
References
-
- De Raedt, et al. Cancer Cell. 2011;(this issue)
-
- Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11–22. - PubMed
-
- Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1–11. - PubMed
-
- Matallanas D, Crespo P. New druggable targets in the Ras pathway? Curr Opin Mol Ther. 2010;12:674–683. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
